BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8250740)

  • 1. Transcranial Doppler evaluation of cerebrovascular reactivity to acetazolamide in normal subjects.
    Mancini M; De Chiara S; Postiglione A; Ferrara LA
    Artery; 1993; 20(4):231-41. PubMed ID: 8250740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cerebrovascular reactivity using transcranial Doppler sonography. Evaluation and comparison of different methods.
    Provinciali L; Minciotti P; Ceravolo G; Sanguinetti CM
    Funct Neurol; 1990; 5(1):33-41. PubMed ID: 2119329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of the acetazolamide effect in patients with extracranial carotid artery disease.
    Stoll M; Hamann GF; Jost V; Bompotti UA; Fitridge R; Schimrigk K
    J Neuroimaging; 1996 Jul; 6(3):144-9. PubMed ID: 8704288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man.
    Lassen Lh; Sperling B; Andersen Ar; Olesen J
    Cephalalgia; 2005 May; 25(5):344-52. PubMed ID: 15839849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of transcranial Doppler sonography mean flow velocity with cerebral blood flow in patients with intracranial pathology.
    Brauer P; Kochs E; Werner C; Bloom M; Policare R; Pentheny S; Yonas H; Kofke WA; Schulte am Esch J
    J Neurosurg Anesthesiol; 1998 Apr; 10(2):80-5. PubMed ID: 9559765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer's disease.
    Likitjaroen Y; Suwanwela NC; Phanthumchinda K
    J Neurol Sci; 2009 Aug; 283(1-2):32-5. PubMed ID: 19375084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular reactivity in patients under long-term acetazolamide treatment.
    Lampl Y; Kesler A; Lorberboyn M; Gadot N; Sadeh M
    Acta Neurol Scand; 2002 Jan; 105(1):59-62. PubMed ID: 11903111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dose-response relationship of acetazolamide on the cerebral blood flow in normal subjects.
    Grossmann WM; Koeberle B
    Cerebrovasc Dis; 2000; 10(1):65-9. PubMed ID: 10629349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of acetazolamide effect in normal persons.
    Hamann GF; Stoll M; Jost V; Bompotti UA; Fitridge R; Schimrigk K
    J Neuroimaging; 1996 Jan; 6(1):29-31. PubMed ID: 8555660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced ct cerebral blood flow and transcranial Doppler.
    Pindzola RR; Balzer JR; Nemoto EM; Goldstein S; Yonas H
    Stroke; 2001 Aug; 32(8):1811-7. PubMed ID: 11486110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-related differences in acetazolamide-induced cerebral vasomotor reactivity.
    Karnik R; Valentin A; Winkler WB; Khaffaf N; Donath P; Slany J
    Stroke; 1996 Jan; 27(1):56-8. PubMed ID: 8553403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of cerebral blood flow and MCA flow velocity measured in healthy volunteers during acetazolamide and CO2 stimulation.
    Ulrich PT; Becker T; Kempski OS
    J Neurol Sci; 1995 Apr; 129(2):120-30. PubMed ID: 7608725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements. Dose, serum concentration, and time course of the response to acetazolamide.
    Dahl A; Russell D; Rootwelt K; Nyberg-Hansen R; Kerty E
    Stroke; 1995 Dec; 26(12):2302-6. PubMed ID: 7491655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of nitroglycerin on cerebrovascular circulation, cerebrovascular CO2-reactivity and blood flow rate in basal cerebral arteries].
    Weyland A; Grüne F; Buhre W; Kazmaier S; Stephan H; Sonntag H
    Anaesthesist; 1996 Nov; 45(11):1037-44. PubMed ID: 9012298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of cerebrovascular reactivity in long-term type 1 diabetes.
    Fülesdi B; Limburg M; Bereczki D; Michels RP; Neuwirth G; Legemate D; Valikovics A; Csiba L
    Diabetes; 1997 Nov; 46(11):1840-5. PubMed ID: 9356034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular reactivity after treatment of unruptured intracranial aneurysms--A transcranial Doppler sonography and acetazolamide study.
    Bøthun ML; Haaland ØA; Logallo N; Svendsen F; Thomassen L; Helland CA
    J Neurol Sci; 2016 Apr; 363():97-103. PubMed ID: 27000230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide.
    Piepgras A; Schmiedek P; Leinsinger G; Haberl RL; Kirsch CM; Einhäupl KM
    Stroke; 1990 Sep; 21(9):1306-11. PubMed ID: 2204147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects.
    Dahl A; Russell D; Nyberg-Hansen R; Rootwelt K; Mowinckel P
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):974-81. PubMed ID: 7929661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebrovascular reactivity in insulin dependent diabetes mellitus studied by an acetazolamide test].
    Fülesdi B; Limburg M; Neuwirth G; Molnár C; Valikovics A; Csiba L
    Orv Hetil; 1996 Sep; 137(39):2137-40. PubMed ID: 8927362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between cerebral regional blood flow velocities and volumetric blood flows and their respective reactivities to acetazolamide.
    Démolis P; Tran Dinh YR; Giudicelli JF
    Stroke; 1996 Oct; 27(10):1835-9. PubMed ID: 8841341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.